Bicarbonates for the prevention of postoperative renal failure in endovascular aortic aneurysm repair: A randomized pilot trial

Anesthesiology Research and Practice

Volumn 2013, Issue , 2013, Pages

  Brulotte, Véronique ^a,b   Leblond, François A ^b   Elkouri, Stéphane ^a   Thérasse, Éric ^a   Pichette, Vincent ^b,c   Beaulieu, Pierre ^a,c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; BIOLOGICAL MARKER; CREATININE; CYSTATIN C; HYPERTENSIVE FACTOR; INTERLEUKIN 18; KIDNEY INJURY MOLECULE 1; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SODIUM CHLORIDE;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CONTROLLED STUDY; ENDOVASCULAR ANEURYSM REPAIR; ENDOVASCULAR AORTIC ANEURYSM REPAIR; FEMALE; HUMAN; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PILOT STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; URINALYSIS;

EID: 84880140314     PISSN: 16876962     EISSN: 16876970     Source Type: Journal    
DOI: 10.1155/2013/467326     Document Type: Article

References (43)

1. The EVAR trial participants, Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurym (EVAR trial 1): randomised controlled trial. The Lancet 2005 365 9478 2179 2186 2-s2.0-20744438829 10.1016/S0140-6736(05)66627-5
2. The EVAR trial participants, Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial. The Lancet 2005 365 9478 2187 2192 2-s2.0-20744453113 10.1016/S0140-6736(05)66628-7
3. Schermerhorn M. L., O'Malley A. J., Jhaveri A., Cotterill P., Pomposelli F., Landon B. E., Endovascular vs. open repair of abdominal aortic aneurysms in the medicare population. The New England Journal of Medicine 2008 358 5 464 474 2-s2.0-38749127156 10.1056/NEJMoa0707348
4. Parmer S. S., Carpenter J. P., Endovascular aneurysm repair with suprarenal vs infrarenal fixation: a study of renal effects. Journal of Vascular Surgery 2006 43 1 19 25 2-s2.0-30544452119 10.1016/j.jvs.2005.09.025
5. Carpenter J. P., Fairman R. M., Barker C. F., Golden M. A., Velazquez O. C., Mitchell M. E., Baum R. A., Endovascular AAA repair in patients with renal insufficiency: strategies for reducing adverse renal events. Cardiovascular Surgery 2001 9 6 559 564 2-s2.0-0034774216 10.1016/S0967-2109(01)00085-0
6. Alsac J., Zarins C. K., Heikkinen M. A., Karwowski J., Arko F. R., Desgranges P., Roudot-Thoraval F., Becquemin J., The impact of aortic endografts on renal function. Journal of Vascular Surgery 2005 41 6 926 930 2-s2.0-20444453327 10.1016/j.jvs.2005.02.024
7. Moore N. N., Lapsley M., Norden A. G., Firth J. D., Gaunt M. E., Varty K., Boyle J. R., Does N-acetylcysteine prevent contrast-induced nephropathy during endovascular AAA repair? A randomized controlled pilot study. Journal of Endovascular Therapy 2006 13 5 660 666 2-s2.0-33750991050 10.1583/06-1833.1
8. Erley C. M., Does hydration prevent radiocontrast-induced acute renal failure? Nephrology Dialysis Transplantation 1999 14 5 1064 1066 2-s2.0-0032918019 10.1093/ndt/14.5.1064
9. Mueller C., Buerkle G., Buettner H. J., Petersen J., Perruchoud A. P., Eriksson U., Marsch S., Roskamm H., Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Archives of Internal Medicine 2002 162 3 329 336 2-s2.0-0037059951
10. Trivedi H. S., Moore H., Nasr S., Aggarwal K., Agrawal A., Goel P., Hewett J., A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clinical Practice 2003 93 1 C29 34 2-s2.0-0042496326
11. Bader B. D., Berger E. D., Heede M. B., Silberbaur I., Duda S., Risler T., Erley C. M., What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? Clinical Nephrology 2004 62 1 1 7 2-s2.0-3242803772
12. Holt S., Radiocontrast media-induced renal injury: saline is effective in prevention. Nephron Clinical Practice 2003 93 1 5 6 2-s2.0-18744385807
13. Mueller C., Prevention of contrast-induced nephropathy with volume supplementation. Kidney International 2006 100 S16 19 2-s2.0-33746864932
14. Gonzales D. A., Norsworthy K. J., Kern S. J., Banks S., Sieving P. C., Star R. A., Natanson C., Danner R. L., A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity. BMC Medicine 2007 5, article 32 2-s2.0-38349106545 10.1186/1741-7015-5-32
15. Trivedi H., Daram S., Szabo A., Bartorelli A. L., Marenzi G., High-dose N-acetylcysteine for the Prevention of Contrast-induced Nephropathy. The American Journal of Medicine 2009 122 9 874 915 2-s2.0-68749089747 10.1016/j.amjmed.2009.01.035
16. Briguori C., Colombo A., Violante A., Balestrieri P., Manganelli F., Elia P. P., Golia B., Lepore S., Riviezzo G., Scarpato P., Focaccio A., Librera M., Bonizzoni E., Ricciardelli B., Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. European Heart Journal 2004 25 3 206 211 2-s2.0-10744233453 10.1016/j.ehj.2003.11.016
17. Baker C. S. R., Wragg A., Kumar S., De Palma R., Baker L. R. I., Knight C. J., A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. Journal of the American College of Cardiology 2003 41 12 2114 2118 2-s2.0-0038648456 10.1016/S0735-1097(03)00487-X
18. Kelly A. M., Dwamena B., Cronin P., Bernstein S. J., Carlos R. C., Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Annals of Internal Medicine 2008 148 4 284 294 2-s2.0-40049091486
19. Weisbord S. D., Palevsky P. M., Strategies for the prevention of contrast-induced acute kidney injury. Current Opinion in Nephrology and Hypertension 2010 19 6 539 549 2-s2.0-78049252959 10.1097/MNH.0b013e32833d42e3
20. Merten G. J., Burgess W. P., Gray L. V., Holleman J. H., Roush T. S., Kowalchuk G. J., Bersin R. M., Van Moore A., Simonton C. A. III, Rittase R. A., Norton H. J., Kennedy T. P., Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. Journal of the American Medical Association 2004 291 19 2328 2334 2-s2.0-2442590642 10.1001/jama.291.19. 2328
21. Briguori C., Airoldi F., D'Andrea D., Bonizzoni E., Morici N., Focaccio A., Michev I., Montorfano M., Carlino M., Cosgrave J., Ricciardelli B., Colombo A., Renal insufficiency following contrast media administration trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 2007 115 1211 1217 2-s2.0-33947716173 10.1161/CIRCULATIONAHA.106.687152
22. Ueda H., Yamada T., Masuda M., Okuyama Y., Morita T., Furukawa Y., Koji T., Iwasaki Y., Okada T., Kawasaki M., Kuramoto Y., Naito T., Fujimoto T., Komuro I., Fukunami M., Prevention of contrast-induced nephropathy by bolus injection of sodium bicarbonate in patients with chronic kidney disease undergoing emergent coronary procedures. The American Journal of Cardiology 2011 107 8 1163 1167 2-s2.0-79953237522 10.1016/j.amjcard.2010.12.012
23. Motohiro M., Kamihata H., Tsujimoto S., Seno T., Manabe K., Isono T., Sutani Y., Yuasa F., Iwasaka T., A new protocol using sodium bicarbonate for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography. The American Journal of Cardiology 2011 107 11 1604 1608 2-s2.0-79956061798 10.1016/j.amjcard.2011.01.045
24. Pakfetrat M., Nikoo M. H., Malekmakan L., Tabandeh M., Roozbeh J., Nasab M. H., Ostovan M. A., Salari S., Kafi M., Vaziri N. M., Adl F., Hosseini M., Khajehdehi P., A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: a randomized, double-blind trial. International Urology and Nephrology 2009 41 3 629 634 2-s2.0-67649989950 10.1007/s11255-008- 9520-y
25. Brar S. S., Shen A. Y., Jorgensen M. B., Kotlewski A., Aharonian V. J., Desai N., Ree M., Shah A. I., Burchette R. J., Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. Journal of the American Medical Association 2008 300 9 1038 1046 2-s2.0-50949083026 10.1001/jama.300.9. 1038
26. Adolph E., Holdt-Lehmann B., Chatterjee T., Paschka S., Prott A., Schneider H., Koerber T., Ince H., Steiner M., Schuff-Werner P., Nienaber C. A., Renal insufficiency following radiocontrast exposure trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy. Coronary Artery Disease 2008 19 6 413 419 2-s2.0-56649093581 10.1097/MCA.0b013e3283021ac6
27. Vasheghani-Farahani A., Sadigh G., Kassaian S. E., Khatami S. M. R., Fotouhi A., Razavi S. A. H., Mansournia M. A., Yamini-Sharif A., Amirzadegan A., Salarifar M., Sadeghian S., Davoodi G., Borumand M. A., Esfehani F. A., Darabian S., Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial. The American Journal of Kidney Diseases 2009 54 4 610 618 2-s2.0-70349580111 10.1053/j.ajkd.2009.05.016
28. Zoungas S., Ninomiya T., Huxley R., Cass A., Jardine M., Gallagher M., Patel A., Vasheghani-Farahani A., Sadigh G., Perkovic V., Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Annals of Internal Medicine 2009 151 9 631 638 2-s2.0-70450220298 10.1059/0003-4819-151-9-200911030-00008
29. Kunadian V., Zaman A., Spyridopoulos I., Qiu W., Sodium bicarbonate for the prevention of contrast induced nephropathy: a meta-analysis of published clinical trials. European Journal of Radiology 2011 79 1 48 55 2-s2.0-78049390634 10.1016/j.ejrad.2009.12.015
30. Soni S. S., Ronco C., Katz N., Cruz D. N., Early diagnosis of acute kidney injury: the promise of novel biomarkers. Blood Purification 2009 28 3 165 174 2-s2.0-67649886919 10.1159/000227785
31. Mishra J., Qing M. A., Prada A., Mitsnefes M., Zahedi K., Yang J., Barasch J., Devarajan P., Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. Journal of the American Society of Nephrology 2003 14 10 2534 2543 2-s2.0-0141678253 10.1097/01.ASN.0000088027.54400.C6
32. Hirsch R., Dent C., Pfriem H., Allen J., Beekman R. H. III, Ma Q., Dastrala S., Bennett M., Mitsnefes M., Devarajan P., NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatric Nephrology 2007 22 12 2089 2095 2-s2.0-36048965159 10.1007/s00467-007-0601-4
33. Ling W., Zhaohui N., Ben H., Leyi G., Jianping L., Huili D., Jiaqi Q., Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron Clinical Practice 2008 108 3 c176 c181 2-s2.0-42549104621 10.1159/000117814
34. Cruz D. N., Goh C. Y., Haase-Fielitz A., Ronco C., Haase M., Early biomarkers of renal injury. Congestive Heart Failure 2010 16 1 S25 S31 2-s2.0-77955163547 10.1111/j.1751-7133.2010.00163.x
35. Malyszko J., Bachorzewska-Gajewska H., Poniatowski B., Malyszko J. S., Dobrzycki S., Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease. Renal Failure 2009 31 10 910 919 2-s2.0-73649142046 10.3109/08860220903216113
36. Sethi K., Diamond L. H., Aminoglycoside nephrotoxicity and its predictability. Nephron 1981 27 4-5 265 270 2-s2.0-0019408407
37. Roche G., Brugerolle B., Straczek J., Value of the assay of 4 urinary enzyme activities in the diagnosis of the infectious or toxic (aminoglycosides) origin of a renal disease. La Revue De MéDecine Interne 1983 4 327 334
38. Hartmann H. G., Braedel H. E., Jutzler G. A., Detection of renal tubular lesions after abdominal aortography and selective renal arteriography by quantitative measurements of brush-border enzymes in the urine. Nephron 1985 39 2 95 101 2-s2.0-0021967788
39. Wethuyzen J., Urinary protein excretion following coronary angiography using a non-toxic radiocontrast agent. Annals of Clinical Biochemistry 1996 33 349 351
40. Mehta R. L., Kellum J. A., Shah S. V., Molitoris B. A., Ronco C., Warnock D. G., Levin A., Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Critical Care 2007 11 2, article R31 2-s2.0-34447249446
41. Mehran R., Aymong E. D., Nikolsky E., Lasic Z., Iakovou I., Fahy M., Mintz G. S., Lansky A. J., Moses J. W., Stone G. W., Leon M. B., Dangas G., A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. Journal of the American College of Cardiology 2004 44 7 1393 1399 2-s2.0-4644296839 10.1016/j.jacc.2004.06.068
42. Meier P., Ko D. T., Tamura A., Tamhane U., Gurm H. S., Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis. BMC Medicine 2009 7, article 23 2-s2.0-66149163816 10.1186/1741-7015-7-23
43. Maioli M., Toso A., Leoncini M., Gallopin M., Tedeschi D., Micheletti C., Bellandi F., Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing Coronary angiography or intervention. Journal of the American College of Cardiology 2008 52 8 599 604 2-s2.0-48849097250 10.1016/j.jacc.2008.05.026